bf/NASDAQ:JYNT_icon.jpeg

COM:THEJOINT

The Joint Chiropractic

  • Stock

USD

Last Close

11.57

22/11 21:00

Market Cap

189.57M

Beta: -

Volume Today

26.46K

Avg: -

Company Overview

Metric
Company NameThe Joint Corp.Eddie V's
SymbolJYNT
MSH IDCOM:THEJOINTCOM:EDDIEV
MarketSTOCKSPRIVATE
SectorHealthcareConsumer Services
IndustryMedical - Care FacilitiesRestaurants
CountryUSUS
Stage
Employee Count444
Websitethejoint.comeddiev.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap189.57M
Enterprise Value
Monthly Web Traffic348.87K199.17K
Web Traffic Growth-0.610.48
Valuation
Raised Capital

Financial Performance

Metric
Revenue117.70M
Revenue (LTM)
Revenue (NTM)
Gross Profit98.57M
EBITDA9.14M
Operating Income559.52K
Net Income-9.75M
EPS-0.66
Diluted EPS-0.66
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.89
Operating Profit Margin0.01
EBITDA Margin0.08
Net Profit Margin-0.08
Return on Equity-0.29
Return on Assets-0.11
Return on Capital Employed0.03

Valuation Multiples

Metric
P/E Ratio72.67
P/B Ratio4.00
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio2.18
EV Multiple23.24

Operational Metrics

Metric
Days Sales Outstanding11.59
Days Payables Outstanding65.73
Days Inventory Outstanding
Operating Cycle11.52
Cash Conversion Cycle-23.68
Asset Turnover1.46

Cash Flow Metrics

Metric
Operating Cash Flow14.68M
Free Cash Flow9.68M
Cash Flow to Debt2.54
Operating Cash Flow/Sales0.12
Free Cash Flow Yield0.08

Balance Sheet Metrics

Metric
Cash & Equivalents19.21M
Accounts Receivable192.35K
Inventory
Goodwill7.35M
Debt to Capitalization0.38
Debt to Assets0.25
Current Ratio1.03
Quick Ratio1.31

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.01
R&D to Revenue
SG&A to Revenue0.68